LOGO
LOGO

Is NAGE's Pullback A Second Chance For Investors?

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
happyaging 13102025 lt

"Aging happy and well, instead of sad and sick, is at least under some personal control. We have considerable control over our weight, our exercise, our education, and our abuse of cigarettes and alcohol…," said George E. Vaillant, a renowned Professor of Psychiatry at Harvard Medical School and the Department of Psychiatry, Brigham and Women's Hospital. In today's world, that personal control is evolving - extending beyond lifestyle choices to include how we support our biology at the cellular level.

The stock we are bringing to your attention today is that of Niagen Bioscience Inc. (NAGE), a company pioneering the future of healthy aging through NAD+ science.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19